We service the life sciences industry with a concentration on pharmaceutical manufacturers. We cover commercialization topics across all phases of product development and life cycles. We are highly skilled at aligning diverse commercial teams to develop holistic strategies that ensure products find their way to patients consistent with the patient and provider experience that brand wants to set.
External link for Blue Fin Group, an IntegriChain Company
8 Penn Center
1628 JFK Blvd., Suite 300
Philadelphia, PA 19103, US
Blue Fin Group, an IntegriChain Company reposted this
Our Access Insights Conference is where your pharmaceutical commercialization strategy truly comes to life. It's the only conference that connects high-level vision with the real-world tactics you need to boost net revenue and improve patient access. Don't miss out on vital IRA Operational Readiness insights! Register today to secure your spot: https://lnkd.in/eFeJcVYj
Blue Fin Group, an IntegriChain Company reposted this
Ready to unlock the future of pharma commercialization? Success in today's complex landscape demands a seamless blend of strategy, technology, and execution. Join us at Access Insights, the only conference designed to bridge the gap between high-level vision and the real-world tactics that drive net revenue optimization and patient access. You'll walk away with a clear roadmap for the next decade of commercialization success, including crucial insights on Healthcare Policy Interpretation in the New Administration. Don't miss out – register today: https://lnkd.in/eFeJcVYj
Blue Fin Group, an IntegriChain Company reposted this
Join us at Access Insights, the only conference dedicated to the entire spectrum of pharma commercialization. We bridge the gap between big-picture strategy and the practical tactics that boost net revenue and improve patient access. This weekend is your last chance for early bird pricing. Secure your ticket today: https://lnkd.in/eFeJcVYj
Blue Fin Group, an IntegriChain Company reposted this
William Roth continues his series with Pharmaceutical Commerce, Popping the Gross-to-Net Bubble Part IV, by dissecting the core difference: how the ASP-based medical benefit resists the bubble, while the pharmacy benefit remains vulnerable due to high list prices and rebate structures. Unpack the details in his latest blog: https://lnkd.in/e3Tq3JQ5
Blue Fin Group, an IntegriChain Company reposted this
Join us and Blue Fin Group, an IntegriChain Company, at the Access Insights Conference from October 27-29, 2025 at the The Mayflower Hotel, Autograph Collection. Get the latest insights on: ~Pricing, Policy, and Reimbursement: Mastering MFP readiness, policy shifts, 340B decisions, and price transparency. ~Data and Technology: Achieving IRA and 340B operational readiness, optimizing data use, and leveraging AI/ML innovations. ~Business and Strategy: Transforming net revenue access, optimizing portfolio mix, and adapting to evolving stakeholder economics. Score an early bird discount today: https://lnkd.in/eFeJcVYj
Blue Fin Group, an IntegriChain Company reposted this
Join us at Access Insights, October 27-29 at The Mayflower Hotel, Autograph Collection, to discover the future of pharma commercialization. Gain actionable strategies, technology insights, and execution tactics to drive results. Register now to secure your place: https://lnkd.in/eFeJcVYj
Blue Fin Group, an IntegriChain Company reposted this
Want to crack the code on balancing patient access and net revenue in pharma? Don't miss William Roth's keynote session at our Access Insights Conference in Washington, D.C. offering bold insights on overcoming the gross-to-net challenge. This isn't just a conference; it's where the brightest minds in the industry converge to drive real change. Explore the agenda and register today with early bird pricing: https://lnkd.in/eFeJcVYj
Blue Fin Group, an IntegriChain Company reposted this
Join William Roth and Laura Jensen at 1PM today during the Asembia Specialty Pharmacy Summit to explore pioneering strategies in medication access and care management. Learn how to empower patients and achieve superior outcomes.
Rich Prest is a valued member of our team! Rich is a Senior Principal at Blue Fin Group and an industry thought leader in patient access and gross-to-net strategies. Rich excels in diagnosing business problems and uncovering opportunities across a spectrum of commercial topics, including marketing, value and market access, field sales, pharmacy and distribution, patient services, finance, government pricing, and operations. We are fortunate to have Rich as a critical member of our team. If you're seeking to be part of a team that values its members, explore our career opportunities here: https://lnkd.in/ep3DQ2nc
Blue Fin Group, an IntegriChain Company reposted this
What's next for pharmaceutical market access? Following our initial exploration of the Inflation Reduction Act (IRA) in Part 1, this session, moderated by Reena Patel of Blue Fin Group, an IntegriChain Company, delves into the impact of innovative distribution models, shifting payer dynamics in provider markets, and the critical role of early commercialization planning. Part 2 Blog: https://lnkd.in/eUe3QYnD Part 1 Blog: https://lnkd.in/e8EKqezu